Goldman Sachs’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,200
| Closed | -$360K | – | 6207 |
|
|
2024
Q4 | $360K | Hold |
1,200
| – | – | ﹤0.01% | 5416 |
|
|
2024
Q3 | $488K | Hold |
1,200
| – | – | ﹤0.01% | 5065 |
|
|
2024
Q2 | $386K | Hold |
1,200
| – | – | ﹤0.01% | 4970 |
|
|
2024
Q1 | $400K | Buy |
+1,200
| New | +$367K | ﹤0.01% | 4849 |
|
|
2022
Q2 | – | Sell |
-13,000
| Closed | -$3.26M | – | 6557 |
|
|
2022
Q1 | $3.26M | Buy |
13,000
+5,200
| +67% | +$1.31M | ﹤0.01% | 3769 |
|
|
2021
Q4 | $2M | Buy |
+7,800
| New | +$1.91M | ﹤0.01% | 4245 |
|
|
2021
Q1 | – | Sell |
-9,700
| Closed | -$1.59M | – | 6177 |
|
|
2020
Q4 | $1.59M | Sell |
9,700
-110,000
| -92% | -$16.1M | ﹤0.01% | 3889 |
|
|
2020
Q3 | $14.9M | Buy |
+119,700
| New | +$14.8M | ﹤0.01% | 1980 |
|
|
2020
Q2 | – | Sell |
-37,500
| Closed | -$3.37M | – | 5315 |
|
|
2020
Q1 | $3.37M | Buy |
+37,500
| New | +$4.86M | ﹤0.01% | 2942 |
|
|
2019
Q1 | – | Sell |
-60,000
| Closed | -$7.47M | – | 5263 |
|
|
2018
Q4 | $7.47M | Sell |
60,000
-4,300
| -7% | -$577K | ﹤0.01% | 2554 |
|
|
2018
Q3 | $8.95M | Buy |
+64,300
| New | +$8M | ﹤0.01% | 2548 |
|
|
2018
Q1 | – | Sell |
-62,600
| Closed | -$5.5M | – | 6086 |
|
|
2017
Q4 | $5.5M | Sell |
62,600
-98,800
| -61% | -$7.94M | ﹤0.01% | 2941 |
|
|
2017
Q3 | $12.8M | Buy |
161,400
+92,700
| +135% | +$7.46M | ﹤0.01% | 2344 |
|
|
2017
Q2 | $5.99M | Sell |
68,700
-40,200
| -37% | -$3.4M | ﹤0.01% | 2912 |
|
|
2017
Q1 | $9.69M | Sell |
108,900
-166,400
| -60% | -$13.9M | ﹤0.01% | 2436 |
|
|
2016
Q4 | $20.4M | Buy |
275,300
+71,200
| +35% | +$5.33M | 0.01% | 1944 |
|
|
2016
Q3 | $15.4M | Sell |
204,100
-143,700
| -41% | -$11M | ﹤0.01% | 2094 |
|
|
2016
Q2 | $26.8M | Buy |
347,800
+105,400
| +43% | +$8.32M | 0.01% | 1584 |
|
|
2016
Q1 | $18.9M | Sell |
242,400
-151,800
| -39% | -$10.6M | 0.01% | 1758 |
|
|
2015
Q4 | $26.7M | Buy |
394,200
+263,000
| +200% | +$18.3M | 0.01% | 1543 |
|
|
2015
Q3 | $10.2M | Sell |
131,200
-329,200
| -72% | -$29.1M | ﹤0.01% | 2245 |
|
|
2015
Q2 | $41.8M | Sell |
460,400
-259,700
| -36% | -$20.8M | 0.01% | 1239 |
|
|
2015
Q1 | $54.2M | Buy |
720,100
+630,400
| +703% | +$45.3M | 0.02% | 1036 |
|
|
2014
Q4 | $6.58M | Sell |
89,700
-130,600
| -59% | -$9.18M | ﹤0.01% | 2723 |
|
|
2014
Q3 | $15.5M | Buy |
220,300
+191,300
| +660% | +$12.6M | ﹤0.01% | 2004 |
|
|
2014
Q2 | $1.64M | Buy |
+29,000
| New | +$1.53M | ﹤0.01% | 4199 |
|
|
2014
Q1 | – | Sell |
-10,700
| Closed | -$510K | – | 6824 |
|
|
2013
Q4 | $510K | Sell |
10,700
-4,000
| -27% | -$185K | ﹤0.01% | 5281 |
|
|
2013
Q3 | $628K | Sell |
14,700
-27,800
| -65% | -$1.09M | ﹤0.01% | 4981 |
|
|
2013
Q2 | $1.53M | Buy |
+42,500
| New | +$1.64M | ﹤0.01% | 3980 |
|
Other funds holding HCA
VCM
VPM
Goldman Sachs's HCA Position: Q1 2026 in Review
Goldman Sachs increased its HCA Healthcare (HCA) stake by 21% in Q1 2026, buying an estimated $183M and bringing the position to 2,136,072 shares worth $1.01B. The position accounts for 0.12% of the portfolio, ranked #166.
Goldman Sachs first reported a position in HCA in Q2 2013 and has held it in 52 quarters since. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- Goldman Sachs held 2,136,072 shares of HCA Healthcare worth $1.01B as of Q1 2026.
- Goldman Sachs bought 363,729 HCA Healthcare shares in Q1 2026, an estimated $183M.
- HCA Healthcare made up 0.12% of Goldman Sachs's portfolio in Q1 2026, its #166 holding.
- Goldman Sachs first reported a position in HCA Healthcare in Q2 2013 and has held it in 52 quarters since.
- 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.